Global Cardiology Radiopharmaceuticals Market Research Report 2025(Status and Outlook)
Report Overview
Cardiology radiopharmaceuticals are specialized radioactive compounds used in nuclear medicine imaging to diagnose and monitor cardiovascular diseases, including myocardial perfusion imaging (MPI) for coronary artery disease, assessment of cardiac function, and detection of inflammation or infection in heart tissues. These agents, such as technetium-99m (Tc-99m)-based tracers (e.g., sestamibi or tetrofosmin) and thallium-201, emit gamma rays that are detected by single-photon emission computed tomography (SPECT) or positron emission tomography (PET) scanners, providing high-resolution images of blood flow, metabolism, and tissue viability. Their role is critical in non-invasive cardiac diagnostics, offering insights into ischemia, infarction, and cardiomyopathy while guiding treatment decisions. The market for these pharmaceuticals is driven by the growing prevalence of cardiovascular diseases, advancements in imaging technologies, and the increasing adoption of hybrid modalities like SPECT/CT and PET/CT. At the same time, challenges such as supply chain vulnerabilities (e.g., reliance on nuclear reactors for isotope production), regulatory hurdles, and competition from alternative imaging techniques influence market dynamics. Emerging trends include the development of novel tracers with longer half-lives, improved targeting capabilities, and the integration of artificial intelligence for enhanced image analysis, positioning cardiology radiopharmaceuticals as a key segment in precision medicine for cardiovascular care.
This report provides a deep insight into the global Cardiology Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cardiology Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cardiology Radiopharmaceuticals market in any manner.
Global Cardiology Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GE Healthcare
Cardinal Health
Curium Pharma
Lantheus Medical Imaging
Inc.
Eczac?ba?? Monrol Nuclear Products
Novartis International AG
Siemens
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Jubilant Life Sciences
Bracco
Market Segmentation (by Type)
Technetium-99
Fluorine-18
Gallium-67
Others
Market Segmentation (by Application)
Therapeutic Use
Diagnostic Use
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cardiology Radiopharmaceuticals Market
Overview of the regional outlook of the Cardiology Radiopharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cardiology Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cardiology Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Cardiology radiopharmaceuticals are specialized radioactive compounds used in nuclear medicine imaging to diagnose and monitor cardiovascular diseases, including myocardial perfusion imaging (MPI) for coronary artery disease, assessment of cardiac function, and detection of inflammation or infection in heart tissues. These agents, such as technetium-99m (Tc-99m)-based tracers (e.g., sestamibi or tetrofosmin) and thallium-201, emit gamma rays that are detected by single-photon emission computed tomography (SPECT) or positron emission tomography (PET) scanners, providing high-resolution images of blood flow, metabolism, and tissue viability. Their role is critical in non-invasive cardiac diagnostics, offering insights into ischemia, infarction, and cardiomyopathy while guiding treatment decisions. The market for these pharmaceuticals is driven by the growing prevalence of cardiovascular diseases, advancements in imaging technologies, and the increasing adoption of hybrid modalities like SPECT/CT and PET/CT. At the same time, challenges such as supply chain vulnerabilities (e.g., reliance on nuclear reactors for isotope production), regulatory hurdles, and competition from alternative imaging techniques influence market dynamics. Emerging trends include the development of novel tracers with longer half-lives, improved targeting capabilities, and the integration of artificial intelligence for enhanced image analysis, positioning cardiology radiopharmaceuticals as a key segment in precision medicine for cardiovascular care.
This report provides a deep insight into the global Cardiology Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cardiology Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cardiology Radiopharmaceuticals market in any manner.
Global Cardiology Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GE Healthcare
Cardinal Health
Curium Pharma
Lantheus Medical Imaging
Inc.
Eczac?ba?? Monrol Nuclear Products
Novartis International AG
Siemens
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Jubilant Life Sciences
Bracco
Market Segmentation (by Type)
Technetium-99
Fluorine-18
Gallium-67
Others
Market Segmentation (by Application)
Therapeutic Use
Diagnostic Use
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cardiology Radiopharmaceuticals Market
Overview of the regional outlook of the Cardiology Radiopharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cardiology Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cardiology Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cardiology Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Cardiology Radiopharmaceuticals Segment by Type
1.2.2 Cardiology Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CARDIOLOGY RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cardiology Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cardiology Radiopharmaceuticals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CARDIOLOGY RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cardiology Radiopharmaceuticals Product Life Cycle
3.3 Global Cardiology Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Cardiology Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Cardiology Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cardiology Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cardiology Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Cardiology Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cardiology Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CARDIOLOGY RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Cardiology Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CARDIOLOGY RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cardiology Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cardiology Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 CARDIOLOGY RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cardiology Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Cardiology Radiopharmaceuticals Market Size Market Share by Type (2020-2025)
6.4 Global Cardiology Radiopharmaceuticals Price by Type (2020-2025)
7 CARDIOLOGY RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cardiology Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Cardiology Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Cardiology Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 CARDIOLOGY RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Cardiology Radiopharmaceuticals Sales by Region
8.1.1 Global Cardiology Radiopharmaceuticals Sales by Region
8.1.2 Global Cardiology Radiopharmaceuticals Sales Market Share by Region
8.2 Global Cardiology Radiopharmaceuticals Market Size by Region
8.2.1 Global Cardiology Radiopharmaceuticals Market Size by Region
8.2.2 Global Cardiology Radiopharmaceuticals Market Size Market Share by Region
8.3 North America
8.3.1 North America Cardiology Radiopharmaceuticals Sales by Country
8.3.2 North America Cardiology Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cardiology Radiopharmaceuticals Sales by Country
8.4.2 Europe Cardiology Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cardiology Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Cardiology Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cardiology Radiopharmaceuticals Sales by Country
8.6.2 South America Cardiology Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cardiology Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Cardiology Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CARDIOLOGY RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Cardiology Radiopharmaceuticals by Region(2020-2025)
9.2 Global Cardiology Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cardiology Radiopharmaceuticals Production
9.4.1 North America Cardiology Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cardiology Radiopharmaceuticals Production
9.5.1 Europe Cardiology Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cardiology Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Cardiology Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cardiology Radiopharmaceuticals Production (2020-2025)
9.7.1 China Cardiology Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GE Healthcare
10.1.1 GE Healthcare Basic Information
10.1.2 GE Healthcare Cardiology Radiopharmaceuticals Product Overview
10.1.3 GE Healthcare Cardiology Radiopharmaceuticals Product Market Performance
10.1.4 GE Healthcare Business Overview
10.1.5 GE Healthcare SWOT Analysis
10.1.6 GE Healthcare Recent Developments
10.2 Cardinal Health
10.2.1 Cardinal Health Basic Information
10.2.2 Cardinal Health Cardiology Radiopharmaceuticals Product Overview
10.2.3 Cardinal Health Cardiology Radiopharmaceuticals Product Market Performance
10.2.4 Cardinal Health Business Overview
10.2.5 Cardinal Health SWOT Analysis
10.2.6 Cardinal Health Recent Developments
10.3 Curium Pharma
10.3.1 Curium Pharma Basic Information
10.3.2 Curium Pharma Cardiology Radiopharmaceuticals Product Overview
10.3.3 Curium Pharma Cardiology Radiopharmaceuticals Product Market Performance
10.3.4 Curium Pharma Business Overview
10.3.5 Curium Pharma SWOT Analysis
10.3.6 Curium Pharma Recent Developments
10.4 Lantheus Medical Imaging
10.4.1 Lantheus Medical Imaging Basic Information
10.4.2 Lantheus Medical Imaging Cardiology Radiopharmaceuticals Product Overview
10.4.3 Lantheus Medical Imaging Cardiology Radiopharmaceuticals Product Market Performance
10.4.4 Lantheus Medical Imaging Business Overview
10.4.5 Lantheus Medical Imaging Recent Developments
10.5 Inc.
10.5.1 Inc. Basic Information
10.5.2 Inc. Cardiology Radiopharmaceuticals Product Overview
10.5.3 Inc. Cardiology Radiopharmaceuticals Product Market Performance
10.5.4 Inc. Business Overview
10.5.5 Inc. Recent Developments
10.6 Eczac?ba?? Monrol Nuclear Products
10.6.1 Eczac?ba?? Monrol Nuclear Products Basic Information
10.6.2 Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Overview
10.6.3 Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Market Performance
10.6.4 Eczac?ba?? Monrol Nuclear Products Business Overview
10.6.5 Eczac?ba?? Monrol Nuclear Products Recent Developments
10.7 Novartis International AG
10.7.1 Novartis International AG Basic Information
10.7.2 Novartis International AG Cardiology Radiopharmaceuticals Product Overview
10.7.3 Novartis International AG Cardiology Radiopharmaceuticals Product Market Performance
10.7.4 Novartis International AG Business Overview
10.7.5 Novartis International AG Recent Developments
10.8 Siemens
10.8.1 Siemens Basic Information
10.8.2 Siemens Cardiology Radiopharmaceuticals Product Overview
10.8.3 Siemens Cardiology Radiopharmaceuticals Product Market Performance
10.8.4 Siemens Business Overview
10.8.5 Siemens Recent Developments
10.9 China Isotope and Radiation
10.9.1 China Isotope and Radiation Basic Information
10.9.2 China Isotope and Radiation Cardiology Radiopharmaceuticals Product Overview
10.9.3 China Isotope and Radiation Cardiology Radiopharmaceuticals Product Market Performance
10.9.4 China Isotope and Radiation Business Overview
10.9.5 China Isotope and Radiation Recent Developments
10.10 Yantai Dongcheng Pharmaceutical
10.10.1 Yantai Dongcheng Pharmaceutical Basic Information
10.10.2 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Overview
10.10.3 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Market Performance
10.10.4 Yantai Dongcheng Pharmaceutical Business Overview
10.10.5 Yantai Dongcheng Pharmaceutical Recent Developments
10.11 Jubilant Life Sciences
10.11.1 Jubilant Life Sciences Basic Information
10.11.2 Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Overview
10.11.3 Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Market Performance
10.11.4 Jubilant Life Sciences Business Overview
10.11.5 Jubilant Life Sciences Recent Developments
10.12 Bracco
10.12.1 Bracco Basic Information
10.12.2 Bracco Cardiology Radiopharmaceuticals Product Overview
10.12.3 Bracco Cardiology Radiopharmaceuticals Product Market Performance
10.12.4 Bracco Business Overview
10.12.5 Bracco Recent Developments
11 CARDIOLOGY RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Cardiology Radiopharmaceuticals Market Size Forecast
11.2 Global Cardiology Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cardiology Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Cardiology Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Cardiology Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cardiology Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Cardiology Radiopharmaceuticals Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Cardiology Radiopharmaceuticals by Type (2026-2033)
12.1.2 Global Cardiology Radiopharmaceuticals Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Cardiology Radiopharmaceuticals by Type (2026-2033)
12.2 Global Cardiology Radiopharmaceuticals Market Forecast by Application (2026-2033)
12.2.1 Global Cardiology Radiopharmaceuticals Sales (K Units) Forecast by Application
12.2.2 Global Cardiology Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cardiology Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Cardiology Radiopharmaceuticals Segment by Type
1.2.2 Cardiology Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CARDIOLOGY RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cardiology Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cardiology Radiopharmaceuticals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CARDIOLOGY RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cardiology Radiopharmaceuticals Product Life Cycle
3.3 Global Cardiology Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Cardiology Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Cardiology Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cardiology Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cardiology Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Cardiology Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cardiology Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CARDIOLOGY RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Cardiology Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CARDIOLOGY RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cardiology Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cardiology Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 CARDIOLOGY RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cardiology Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Cardiology Radiopharmaceuticals Market Size Market Share by Type (2020-2025)
6.4 Global Cardiology Radiopharmaceuticals Price by Type (2020-2025)
7 CARDIOLOGY RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cardiology Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Cardiology Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Cardiology Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 CARDIOLOGY RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Cardiology Radiopharmaceuticals Sales by Region
8.1.1 Global Cardiology Radiopharmaceuticals Sales by Region
8.1.2 Global Cardiology Radiopharmaceuticals Sales Market Share by Region
8.2 Global Cardiology Radiopharmaceuticals Market Size by Region
8.2.1 Global Cardiology Radiopharmaceuticals Market Size by Region
8.2.2 Global Cardiology Radiopharmaceuticals Market Size Market Share by Region
8.3 North America
8.3.1 North America Cardiology Radiopharmaceuticals Sales by Country
8.3.2 North America Cardiology Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cardiology Radiopharmaceuticals Sales by Country
8.4.2 Europe Cardiology Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cardiology Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Cardiology Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cardiology Radiopharmaceuticals Sales by Country
8.6.2 South America Cardiology Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cardiology Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Cardiology Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CARDIOLOGY RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Cardiology Radiopharmaceuticals by Region(2020-2025)
9.2 Global Cardiology Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cardiology Radiopharmaceuticals Production
9.4.1 North America Cardiology Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cardiology Radiopharmaceuticals Production
9.5.1 Europe Cardiology Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cardiology Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Cardiology Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cardiology Radiopharmaceuticals Production (2020-2025)
9.7.1 China Cardiology Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Cardiology Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GE Healthcare
10.1.1 GE Healthcare Basic Information
10.1.2 GE Healthcare Cardiology Radiopharmaceuticals Product Overview
10.1.3 GE Healthcare Cardiology Radiopharmaceuticals Product Market Performance
10.1.4 GE Healthcare Business Overview
10.1.5 GE Healthcare SWOT Analysis
10.1.6 GE Healthcare Recent Developments
10.2 Cardinal Health
10.2.1 Cardinal Health Basic Information
10.2.2 Cardinal Health Cardiology Radiopharmaceuticals Product Overview
10.2.3 Cardinal Health Cardiology Radiopharmaceuticals Product Market Performance
10.2.4 Cardinal Health Business Overview
10.2.5 Cardinal Health SWOT Analysis
10.2.6 Cardinal Health Recent Developments
10.3 Curium Pharma
10.3.1 Curium Pharma Basic Information
10.3.2 Curium Pharma Cardiology Radiopharmaceuticals Product Overview
10.3.3 Curium Pharma Cardiology Radiopharmaceuticals Product Market Performance
10.3.4 Curium Pharma Business Overview
10.3.5 Curium Pharma SWOT Analysis
10.3.6 Curium Pharma Recent Developments
10.4 Lantheus Medical Imaging
10.4.1 Lantheus Medical Imaging Basic Information
10.4.2 Lantheus Medical Imaging Cardiology Radiopharmaceuticals Product Overview
10.4.3 Lantheus Medical Imaging Cardiology Radiopharmaceuticals Product Market Performance
10.4.4 Lantheus Medical Imaging Business Overview
10.4.5 Lantheus Medical Imaging Recent Developments
10.5 Inc.
10.5.1 Inc. Basic Information
10.5.2 Inc. Cardiology Radiopharmaceuticals Product Overview
10.5.3 Inc. Cardiology Radiopharmaceuticals Product Market Performance
10.5.4 Inc. Business Overview
10.5.5 Inc. Recent Developments
10.6 Eczac?ba?? Monrol Nuclear Products
10.6.1 Eczac?ba?? Monrol Nuclear Products Basic Information
10.6.2 Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Overview
10.6.3 Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Market Performance
10.6.4 Eczac?ba?? Monrol Nuclear Products Business Overview
10.6.5 Eczac?ba?? Monrol Nuclear Products Recent Developments
10.7 Novartis International AG
10.7.1 Novartis International AG Basic Information
10.7.2 Novartis International AG Cardiology Radiopharmaceuticals Product Overview
10.7.3 Novartis International AG Cardiology Radiopharmaceuticals Product Market Performance
10.7.4 Novartis International AG Business Overview
10.7.5 Novartis International AG Recent Developments
10.8 Siemens
10.8.1 Siemens Basic Information
10.8.2 Siemens Cardiology Radiopharmaceuticals Product Overview
10.8.3 Siemens Cardiology Radiopharmaceuticals Product Market Performance
10.8.4 Siemens Business Overview
10.8.5 Siemens Recent Developments
10.9 China Isotope and Radiation
10.9.1 China Isotope and Radiation Basic Information
10.9.2 China Isotope and Radiation Cardiology Radiopharmaceuticals Product Overview
10.9.3 China Isotope and Radiation Cardiology Radiopharmaceuticals Product Market Performance
10.9.4 China Isotope and Radiation Business Overview
10.9.5 China Isotope and Radiation Recent Developments
10.10 Yantai Dongcheng Pharmaceutical
10.10.1 Yantai Dongcheng Pharmaceutical Basic Information
10.10.2 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Overview
10.10.3 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Market Performance
10.10.4 Yantai Dongcheng Pharmaceutical Business Overview
10.10.5 Yantai Dongcheng Pharmaceutical Recent Developments
10.11 Jubilant Life Sciences
10.11.1 Jubilant Life Sciences Basic Information
10.11.2 Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Overview
10.11.3 Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Market Performance
10.11.4 Jubilant Life Sciences Business Overview
10.11.5 Jubilant Life Sciences Recent Developments
10.12 Bracco
10.12.1 Bracco Basic Information
10.12.2 Bracco Cardiology Radiopharmaceuticals Product Overview
10.12.3 Bracco Cardiology Radiopharmaceuticals Product Market Performance
10.12.4 Bracco Business Overview
10.12.5 Bracco Recent Developments
11 CARDIOLOGY RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Cardiology Radiopharmaceuticals Market Size Forecast
11.2 Global Cardiology Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cardiology Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Cardiology Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Cardiology Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cardiology Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Cardiology Radiopharmaceuticals Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Cardiology Radiopharmaceuticals by Type (2026-2033)
12.1.2 Global Cardiology Radiopharmaceuticals Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Cardiology Radiopharmaceuticals by Type (2026-2033)
12.2 Global Cardiology Radiopharmaceuticals Market Forecast by Application (2026-2033)
12.2.1 Global Cardiology Radiopharmaceuticals Sales (K Units) Forecast by Application
12.2.2 Global Cardiology Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cardiology Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Cardiology Radiopharmaceuticals Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cardiology Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cardiology Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cardiology Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Radiopharmaceuticals as of 2024)
Table 10. Global Market Cardiology Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Cardiology Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cardiology Radiopharmaceuticals Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Cardiology Radiopharmaceuticals Sales by Type (K Units)
Table 26. Global Cardiology Radiopharmaceuticals Market Size by Type (M USD)
Table 27. Global Cardiology Radiopharmaceuticals Sales (K Units) by Type (2020-2025)
Table 28. Global Cardiology Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 29. Global Cardiology Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 30. Global Cardiology Radiopharmaceuticals Market Size Share by Type (2020-2025)
Table 31. Global Cardiology Radiopharmaceuticals Price (USD/Unit) by Type (2020-2025)
Table 32. Global Cardiology Radiopharmaceuticals Sales (K Units) by Application
Table 33. Global Cardiology Radiopharmaceuticals Market Size by Application
Table 34. Global Cardiology Radiopharmaceuticals Sales by Application (2020-2025) & (K Units)
Table 35. Global Cardiology Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 36. Global Cardiology Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 37. Global Cardiology Radiopharmaceuticals Market Share by Application (2020-2025)
Table 38. Global Cardiology Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 39. Global Cardiology Radiopharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 40. Global Cardiology Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. Global Cardiology Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 42. Global Cardiology Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Table 43. North America Cardiology Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 44. North America Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Cardiology Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 46. Europe Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Cardiology Radiopharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Cardiology Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 49. South America Cardiology Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 50. South America Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Cardiology Radiopharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Cardiology Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 53. Global Cardiology Radiopharmaceuticals Production (K Units) by Region(2020-2025)
Table 54. Global Cardiology Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Cardiology Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 56. Global Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. GE Healthcare Basic Information
Table 62. GE Healthcare Cardiology Radiopharmaceuticals Product Overview
Table 63. GE Healthcare Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. GE Healthcare Business Overview
Table 65. GE Healthcare SWOT Analysis
Table 66. GE Healthcare Recent Developments
Table 67. Cardinal Health Basic Information
Table 68. Cardinal Health Cardiology Radiopharmaceuticals Product Overview
Table 69. Cardinal Health Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Cardinal Health Business Overview
Table 71. Cardinal Health SWOT Analysis
Table 72. Cardinal Health Recent Developments
Table 73. Curium Pharma Basic Information
Table 74. Curium Pharma Cardiology Radiopharmaceuticals Product Overview
Table 75. Curium Pharma Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Curium Pharma Business Overview
Table 77. Curium Pharma SWOT Analysis
Table 78. Curium Pharma Recent Developments
Table 79. Lantheus Medical Imaging Basic Information
Table 80. Lantheus Medical Imaging Cardiology Radiopharmaceuticals Product Overview
Table 81. Lantheus Medical Imaging Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Lantheus Medical Imaging Business Overview
Table 83. Lantheus Medical Imaging Recent Developments
Table 84. Inc. Basic Information
Table 85. Inc. Cardiology Radiopharmaceuticals Product Overview
Table 86. Inc. Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Inc. Business Overview
Table 88. Inc. Recent Developments
Table 89. Eczac?ba?? Monrol Nuclear Products Basic Information
Table 90. Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Overview
Table 91. Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Eczac?ba?? Monrol Nuclear Products Business Overview
Table 93. Eczac?ba?? Monrol Nuclear Products Recent Developments
Table 94. Novartis International AG Basic Information
Table 95. Novartis International AG Cardiology Radiopharmaceuticals Product Overview
Table 96. Novartis International AG Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novartis International AG Business Overview
Table 98. Novartis International AG Recent Developments
Table 99. Siemens Basic Information
Table 100. Siemens Cardiology Radiopharmaceuticals Product Overview
Table 101. Siemens Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Siemens Business Overview
Table 103. Siemens Recent Developments
Table 104. China Isotope and Radiation Basic Information
Table 105. China Isotope and Radiation Cardiology Radiopharmaceuticals Product Overview
Table 106. China Isotope and Radiation Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. China Isotope and Radiation Business Overview
Table 108. China Isotope and Radiation Recent Developments
Table 109. Yantai Dongcheng Pharmaceutical Basic Information
Table 110. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Overview
Table 111. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Yantai Dongcheng Pharmaceutical Business Overview
Table 113. Yantai Dongcheng Pharmaceutical Recent Developments
Table 114. Jubilant Life Sciences Basic Information
Table 115. Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Overview
Table 116. Jubilant Life Sciences Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Jubilant Life Sciences Business Overview
Table 118. Jubilant Life Sciences Recent Developments
Table 119. Bracco Basic Information
Table 120. Bracco Cardiology Radiopharmaceuticals Product Overview
Table 121. Bracco Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Bracco Business Overview
Table 123. Bracco Recent Developments
Table 124. Global Cardiology Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Global Cardiology Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Cardiology Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K Units)
Table 127. North America Cardiology Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Cardiology Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K Units)
Table 129. Europe Cardiology Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Cardiology Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K Units)
Table 131. Asia Pacific Cardiology Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Cardiology Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K Units)
Table 133. South America Cardiology Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Cardiology Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Cardiology Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Cardiology Radiopharmaceuticals Sales Forecast by Type (2026-2033) & (K Units)
Table 137. Global Cardiology Radiopharmaceuticals Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Cardiology Radiopharmaceuticals Price Forecast by Type (2026-2033) & (USD/Unit)
Table 139. Global Cardiology Radiopharmaceuticals Sales (K Units) Forecast by Application (2026-2033)
Table 140. Global Cardiology Radiopharmaceuticals Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cardiology Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Cardiology Radiopharmaceuticals Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cardiology Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cardiology Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cardiology Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Radiopharmaceuticals as of 2024)
Table 10. Global Market Cardiology Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Cardiology Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cardiology Radiopharmaceuticals Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Cardiology Radiopharmaceuticals Sales by Type (K Units)
Table 26. Global Cardiology Radiopharmaceuticals Market Size by Type (M USD)
Table 27. Global Cardiology Radiopharmaceuticals Sales (K Units) by Type (2020-2025)
Table 28. Global Cardiology Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 29. Global Cardiology Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 30. Global Cardiology Radiopharmaceuticals Market Size Share by Type (2020-2025)
Table 31. Global Cardiology Radiopharmaceuticals Price (USD/Unit) by Type (2020-2025)
Table 32. Global Cardiology Radiopharmaceuticals Sales (K Units) by Application
Table 33. Global Cardiology Radiopharmaceuticals Market Size by Application
Table 34. Global Cardiology Radiopharmaceuticals Sales by Application (2020-2025) & (K Units)
Table 35. Global Cardiology Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 36. Global Cardiology Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 37. Global Cardiology Radiopharmaceuticals Market Share by Application (2020-2025)
Table 38. Global Cardiology Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 39. Global Cardiology Radiopharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 40. Global Cardiology Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. Global Cardiology Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 42. Global Cardiology Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Table 43. North America Cardiology Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 44. North America Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Cardiology Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 46. Europe Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Cardiology Radiopharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Cardiology Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 49. South America Cardiology Radiopharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 50. South America Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Cardiology Radiopharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Cardiology Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 53. Global Cardiology Radiopharmaceuticals Production (K Units) by Region(2020-2025)
Table 54. Global Cardiology Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Cardiology Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 56. Global Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Cardiology Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. GE Healthcare Basic Information
Table 62. GE Healthcare Cardiology Radiopharmaceuticals Product Overview
Table 63. GE Healthcare Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. GE Healthcare Business Overview
Table 65. GE Healthcare SWOT Analysis
Table 66. GE Healthcare Recent Developments
Table 67. Cardinal Health Basic Information
Table 68. Cardinal Health Cardiology Radiopharmaceuticals Product Overview
Table 69. Cardinal Health Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Cardinal Health Business Overview
Table 71. Cardinal Health SWOT Analysis
Table 72. Cardinal Health Recent Developments
Table 73. Curium Pharma Basic Information
Table 74. Curium Pharma Cardiology Radiopharmaceuticals Product Overview
Table 75. Curium Pharma Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Curium Pharma Business Overview
Table 77. Curium Pharma SWOT Analysis
Table 78. Curium Pharma Recent Developments
Table 79. Lantheus Medical Imaging Basic Information
Table 80. Lantheus Medical Imaging Cardiology Radiopharmaceuticals Product Overview
Table 81. Lantheus Medical Imaging Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Lantheus Medical Imaging Business Overview
Table 83. Lantheus Medical Imaging Recent Developments
Table 84. Inc. Basic Information
Table 85. Inc. Cardiology Radiopharmaceuticals Product Overview
Table 86. Inc. Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Inc. Business Overview
Table 88. Inc. Recent Developments
Table 89. Eczac?ba?? Monrol Nuclear Products Basic Information
Table 90. Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Overview
Table 91. Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Eczac?ba?? Monrol Nuclear Products Business Overview
Table 93. Eczac?ba?? Monrol Nuclear Products Recent Developments
Table 94. Novartis International AG Basic Information
Table 95. Novartis International AG Cardiology Radiopharmaceuticals Product Overview
Table 96. Novartis International AG Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novartis International AG Business Overview
Table 98. Novartis International AG Recent Developments
Table 99. Siemens Basic Information
Table 100. Siemens Cardiology Radiopharmaceuticals Product Overview
Table 101. Siemens Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Siemens Business Overview
Table 103. Siemens Recent Developments
Table 104. China Isotope and Radiation Basic Information
Table 105. China Isotope and Radiation Cardiology Radiopharmaceuticals Product Overview
Table 106. China Isotope and Radiation Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. China Isotope and Radiation Business Overview
Table 108. China Isotope and Radiation Recent Developments
Table 109. Yantai Dongcheng Pharmaceutical Basic Information
Table 110. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Overview
Table 111. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Yantai Dongcheng Pharmaceutical Business Overview
Table 113. Yantai Dongcheng Pharmaceutical Recent Developments
Table 114. Jubilant Life Sciences Basic Information
Table 115. Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Overview
Table 116. Jubilant Life Sciences Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Jubilant Life Sciences Business Overview
Table 118. Jubilant Life Sciences Recent Developments
Table 119. Bracco Basic Information
Table 120. Bracco Cardiology Radiopharmaceuticals Product Overview
Table 121. Bracco Cardiology Radiopharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Bracco Business Overview
Table 123. Bracco Recent Developments
Table 124. Global Cardiology Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Global Cardiology Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Cardiology Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K Units)
Table 127. North America Cardiology Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Cardiology Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K Units)
Table 129. Europe Cardiology Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Cardiology Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K Units)
Table 131. Asia Pacific Cardiology Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Cardiology Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K Units)
Table 133. South America Cardiology Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Cardiology Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Cardiology Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Cardiology Radiopharmaceuticals Sales Forecast by Type (2026-2033) & (K Units)
Table 137. Global Cardiology Radiopharmaceuticals Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Cardiology Radiopharmaceuticals Price Forecast by Type (2026-2033) & (USD/Unit)
Table 139. Global Cardiology Radiopharmaceuticals Sales (K Units) Forecast by Application (2026-2033)
Table 140. Global Cardiology Radiopharmaceuticals Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cardiology Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cardiology Radiopharmaceuticals Market Size (M USD), 2024-2033
Figure 5. Global Cardiology Radiopharmaceuticals Market Size (M USD) (2020-2033)
Figure 6. Global Cardiology Radiopharmaceuticals Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cardiology Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cardiology Radiopharmaceuticals Product Life Cycle
Figure 13. Cardiology Radiopharmaceuticals Sales Share by Manufacturers in 2024
Figure 14. Global Cardiology Radiopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 15. Cardiology Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cardiology Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cardiology Radiopharmaceuticals Revenue in 2024
Figure 18. Industry Chain Map of Cardiology Radiopharmaceuticals
Figure 19. Global Cardiology Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Cardiology Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cardiology Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Cardiology Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Cardiology Radiopharmaceuticals by Type in 2024
Figure 29. Market Size Share of Cardiology Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Size Share of Cardiology Radiopharmaceuticals by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cardiology Radiopharmaceuticals Market Share by Application
Figure 33. Global Cardiology Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Cardiology Radiopharmaceuticals Sales Market Share by Application in 2024
Figure 35. Global Cardiology Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Cardiology Radiopharmaceuticals Market Share by Application in 2024
Figure 37. Global Cardiology Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cardiology Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Cardiology Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Figure 40. North America Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cardiology Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cardiology Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 45. U.S. Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cardiology Radiopharmaceuticals Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cardiology Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cardiology Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cardiology Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cardiology Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 55. Germany Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cardiology Radiopharmaceuticals Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cardiology Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cardiology Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 68. China Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cardiology Radiopharmaceuticals Sales and Growth Rate (K Units)
Figure 79. South America Cardiology Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Cardiology Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Cardiology Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 82. Brazil Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cardiology Radiopharmaceuticals Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cardiology Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cardiology Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cardiology Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cardiology Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Cardiology Radiopharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cardiology Radiopharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cardiology Radiopharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cardiology Radiopharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cardiology Radiopharmaceuticals Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Cardiology Radiopharmaceuticals Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Cardiology Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Cardiology Radiopharmaceuticals Market Share Forecast by Type (2026-2033)
Figure 111. Global Cardiology Radiopharmaceuticals Sales Forecast by Application (2026-2033)
Figure 112. Global Cardiology Radiopharmaceuticals Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Cardiology Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cardiology Radiopharmaceuticals Market Size (M USD), 2024-2033
Figure 5. Global Cardiology Radiopharmaceuticals Market Size (M USD) (2020-2033)
Figure 6. Global Cardiology Radiopharmaceuticals Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cardiology Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cardiology Radiopharmaceuticals Product Life Cycle
Figure 13. Cardiology Radiopharmaceuticals Sales Share by Manufacturers in 2024
Figure 14. Global Cardiology Radiopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 15. Cardiology Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cardiology Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cardiology Radiopharmaceuticals Revenue in 2024
Figure 18. Industry Chain Map of Cardiology Radiopharmaceuticals
Figure 19. Global Cardiology Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Cardiology Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cardiology Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Cardiology Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Cardiology Radiopharmaceuticals by Type in 2024
Figure 29. Market Size Share of Cardiology Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Size Share of Cardiology Radiopharmaceuticals by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cardiology Radiopharmaceuticals Market Share by Application
Figure 33. Global Cardiology Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Cardiology Radiopharmaceuticals Sales Market Share by Application in 2024
Figure 35. Global Cardiology Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Cardiology Radiopharmaceuticals Market Share by Application in 2024
Figure 37. Global Cardiology Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cardiology Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Cardiology Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Figure 40. North America Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cardiology Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cardiology Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 45. U.S. Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cardiology Radiopharmaceuticals Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cardiology Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cardiology Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cardiology Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cardiology Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 55. Germany Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cardiology Radiopharmaceuticals Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cardiology Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cardiology Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 68. China Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cardiology Radiopharmaceuticals Sales and Growth Rate (K Units)
Figure 79. South America Cardiology Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Cardiology Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Cardiology Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 82. Brazil Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cardiology Radiopharmaceuticals Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cardiology Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cardiology Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cardiology Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cardiology Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cardiology Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cardiology Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Cardiology Radiopharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cardiology Radiopharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cardiology Radiopharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cardiology Radiopharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cardiology Radiopharmaceuticals Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Cardiology Radiopharmaceuticals Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Cardiology Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Cardiology Radiopharmaceuticals Market Share Forecast by Type (2026-2033)
Figure 111. Global Cardiology Radiopharmaceuticals Sales Forecast by Application (2026-2033)
Figure 112. Global Cardiology Radiopharmaceuticals Market Share Forecast by Application (2026-2033)
